A single-cell transcriptomic landscape of the lungs of patients with COVID-19
Si Wang,Xiaohong Yao,Shuai Ma,Yifang Ping,Yanling Fan,Shuhui Sun,Zhicheng He,Yu Shi,Liang Sun,Shiqi Xiao,Moshi Song,Jun Cai,Jiaming Li,Rui Tang,Liyun Zhao,Chaofu Wang,Qiaoran Wang,Lei Zhao,Huifang Hu,Xindong Liu,Guoqiang Sun,Lu Chen,Guoqing Pan,Huaiyong Chen,Qingrui Li,Peipei Zhang,Yuanyuan Xu,Huyi Feng,Guo-Guang Zhao,Tianzi Wen,Yungui Yang,Xuequan Huang,Wei Li,Zhenhua Liu,Hongmei Wang,Haibo Wu,Baoyang Hu,Yong Ren,Qi Zhou,Jing Qu,Weiqi Zhang,Guang-Hui Liu,Xiu-Wu Bian
DOI: https://doi.org/10.1038/s41556-021-00796-6
IF: 21.3
2021-12-01
Nature Cell Biology
Abstract:The lung is the primary organ targeted by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), making respiratory failure a leading coronavirus disease 2019 (COVID-19)-related mortality. However, our cellular and molecular understanding of how SARS-CoV-2 infection drives lung pathology is limited. Here we constructed multi-omics and single-nucleus transcriptomic atlases of the lungs of patients with COVID-19, which integrate histological, transcriptomic and proteomic analyses. Our work reveals the molecular basis of pathological hallmarks associated with SARS-CoV-2 infection in different lung and infiltrating immune cell populations. We report molecular fingerprints of hyperinflammation, alveolar epithelial cell exhaustion, vascular changes and fibrosis, and identify parenchymal lung senescence as a molecular state of COVID-19 pathology. Moreover, our data suggest that FOXO3A suppression is a potential mechanism underlying the fibroblast-to-myofibroblast transition associated with COVID-19 pulmonary fibrosis. Our work depicts a comprehensive cellular and molecular atlas of the lungs of patients with COVID-19 and provides insights into SARS-CoV-2-related pulmonary injury, facilitating the identification of biomarkers and development of symptomatic treatments.
cell biology